Operator
Greetings, and welcome to the Amphastar Prescription drugs, Inc. Third Quarter Earnings Name. [Operator Instructions] Please observe that sure statements made throughout this name relating to issues that aren’t historic information, together with, however not restricted to, administration’s outlook or predictions for the long run durations are forward-looking statements. These statements are based mostly solely on info that’s now accessible to us. We encourage you to evaluate the session entitled Ahead-Trying Statements within the press launch issued at this time and the presentation on the corporate’s web site.
Additionally, please confer with our SEC filings, which could be discovered on our web site and the SEC’s web site for a dialogue of quite a few components which will impression our future efficiency. We may also talk about sure non-GAAP measures. Vital info on our use of those measures and reconciliations to the U.S. GAAP could also be present in our earnings launch. Please observe that this convention is being recorded.
Our audio system at this time are Mr. Invoice Peters, CFO; Mr. Dan Dischner, Senior Vice President of Company Communications; and Mr. Tony Marrs, Government Vice President of Regulatory Affairs and Scientific Operations.
I’ll now flip the convention over to your host, Mr. Dan Dischner, Senior Vice President of Company Communications. Please go forward, sir.